Apatinib for metastatic breast cancer in non-clinical trial setting: Satisfying efficacy regardless of previous anti-angiogenic treatment
Tumor BiologyPeer ReviewedYing Lin +72017Journals
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support